123 related articles for article (PubMed ID: 6994867)
21. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
[TBL] [Abstract][Full Text] [Related]
22. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
[TBL] [Abstract][Full Text] [Related]
23. BCG-immunotherapy of L2C guinea pig leukemia.
Dopatka HD; Majer M; Freudenstein H; Hennessen W
Dev Biol Stand; 1977 Apr 13-15; 38():355-8. PubMed ID: 608523
[TBL] [Abstract][Full Text] [Related]
24. [Immunology and BCG therapeutics].
Sánchez Olivas MA; Valencia Zavala MP; Montes Montes J; Sánchez Olivas JA; Flores Méndez I
Rev Alerg Mex; 2008; 55(4):153-63. PubMed ID: 19058494
[TBL] [Abstract][Full Text] [Related]
25. [Growth dynamics of transplantable 2-N-acetylaminofluorene-induced hepatoma treated with BCG vaccine, 5-fluorouracil and surgery].
Jeleń M
Patol Pol; 1983; 34(1):25-39. PubMed ID: 6888980
[No Abstract] [Full Text] [Related]
26. Immunotherapy of a guinea pig hepatoma with living BCG: a frozen liquid and a lyophilized preparation are equally active.
Zbar B; Ribi E; Rapp HJ
Cancer; 1977 Dec; 40(6):2930-2. PubMed ID: 201359
[TBL] [Abstract][Full Text] [Related]
27. [Growth of transplantable Guérin tumor and Morris hepatoma in rats after a single dose of BCG vaccine according to different timetables].
Nowak HF; Cylwik B; Zimnoch L; Jodczyk KJ; Pregowski W; Duda D; Bernaczyk A
Patol Pol; 1981; 32(2):173-84. PubMed ID: 7322639
[No Abstract] [Full Text] [Related]
28. The use of biological response modifiers in parasitic infections.
Ruitenberg EJ; Buys J; Blomjous FJ; de Jong H; Bernadina W
Dev Biol Stand; 1985; 62():129-38. PubMed ID: 3938740
[No Abstract] [Full Text] [Related]
29. Antitumor activity of mycobacterial glycolipid A1.
Reggiardo Z
Infect Immun; 1978 Sep; 21(3):914-7. PubMed ID: 81809
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.
Tokunaga T; Yamamoto H; Shimada S; Abe H; Fukuda T; Fujisawa Y; Furutani Y; Yano O; Kataoka T; Sudo T
J Natl Cancer Inst; 1984 Apr; 72(4):955-62. PubMed ID: 6200641
[TBL] [Abstract][Full Text] [Related]
31. Effect of isoniazid on BCG-mediated tumor immunity.
Romolo JL; Loyd B; Cohen MH
Surg Forum; 1977; 28():158-9. PubMed ID: 364713
[No Abstract] [Full Text] [Related]
32. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.
Ashley MP; Zbar B; Hunter JT; Rapp HJ; Sugimoto T
Cancer Res; 1980 Nov; 40(11):4197-203. PubMed ID: 7471060
[TBL] [Abstract][Full Text] [Related]
33. Getting the Most Out of bacillus Calmette-Guérin for Treatment of Bladder Cancer.
Lamm DL
J Urol; 2016 Jan; 195(1):7-8. PubMed ID: 26456281
[No Abstract] [Full Text] [Related]
34. [Effects of indomethacin and BCG vaccine on growth of transplanted tumors in mice].
Kurunov IuN; Kaledin VI
Eksp Onkol; 1990; 12(6):57-9. PubMed ID: 2261880
[TBL] [Abstract][Full Text] [Related]
35. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
Rentsch CA; Birkhäuser FD; Biot C; Gsponer JR; Bisiaux A; Wetterauer C; Lagranderie M; Marchal G; Orgeur M; Bouchier C; Bachmann A; Ingersoll MA; Brosch R; Albert ML; Thalmann GN
Eur Urol; 2014 Oct; 66(4):677-88. PubMed ID: 24674149
[TBL] [Abstract][Full Text] [Related]
36. Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.
de Jong WH; Steerenberg PA; Kreeftenberg JG; Tiesjema RH; Kruizinga W; van Noorle Jansen LM; Ruitenberg EJ
Cancer Immunol Immunother; 1984; 17(1):18-27. PubMed ID: 6563941
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial.
Peters K; Diokno A; Steinert B; Yuhico M; Mitchell B; Krohta S; Gillette B; Gonzalez J
J Urol; 1997 Jun; 157(6):2090-4. PubMed ID: 9146587
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral BCG therapy of transplanted head and neck tumors in strain 2 guinea pigs.
Bier J; Bier H; Kleinschuster S; Rapp H
Head Neck Surg; 1982; 4(6):457-67. PubMed ID: 7118547
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of BCG induced regression of line 10 hepatocarcinoma in the guinea pig.
Steerenberg PA; De Jong WH; Ruitenberg EJ
In Vivo; 1991; 5(6):655-61. PubMed ID: 1810452
[TBL] [Abstract][Full Text] [Related]
40. Failure of Bacillus Calmette-Guérin therapy in non-muscle-invasive bladder cancer: Definition and treatment options.
Gual Frau J; Palou J; Rodríguez O; Parada R; Breda A; Villavicencio H
Arch Esp Urol; 2016 Sep; 69(7):423-33. PubMed ID: 27617552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
